These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37081695)

  • 21. Cardiac autonomic dysfunction and arterial stiffness among children and adolescents with attention deficit hyperactivity disorder treated with stimulants.
    Kelly AS; Rudser KD; Dengel DR; Kaufman CL; Reiff MI; Norris AL; Metzig AM; Steinberger J
    J Pediatr; 2014 Oct; 165(4):755-9. PubMed ID: 25015574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM; Hughes TE; Jarrar MA; Secnik K; Perwien AR
    J Manag Care Pharm; 2003; 9(5):416-23. PubMed ID: 14613439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attention deficit hyperactivity disorder screening electrocardiograms: a community-based perspective.
    Shahani SA; Evans WN; Mayman GA; Thomas VC
    Pediatr Cardiol; 2014 Mar; 35(3):485-9. PubMed ID: 24141829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents.
    Sikirica V; Haim Erder M; Xie J; Macaulay D; Diener M; Hodgkins P; Wu EQ
    Pharmacoeconomics; 2012 Aug; 30(8):e1-15. PubMed ID: 22788263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
    Mittal S; Boan AD; Kral MC; Lally MD; van Bakergem K; Macias MM; LaRosa A
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study.
    Dalsgaard S; Kvist AP; Leckman JF; Nielsen HS; Simonsen M
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):302-10. PubMed ID: 24956171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Associated with Attention Deficit Hyperactivity Disorder Medication Use in Community Care Settings.
    Kamimura-Nishimura KI; Epstein JN; Froehlich TE; Peugh J; Brinkman WB; Baum R; Gardner W; Langberg JM; Lichtenstein P; Chen D; Kelleher KJ
    J Pediatr; 2019 Oct; 213():155-162.e1. PubMed ID: 31300310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
    Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
    Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.
    Vitiello B; Elliott GR; Swanson JM; Arnold LE; Hechtman L; Abikoff H; Molina BS; Wells K; Wigal T; Jensen PS; Greenhill LL; Kaltman JR; Severe JB; Odbert C; Hur K; Gibbons R
    Am J Psychiatry; 2012 Feb; 169(2):167-77. PubMed ID: 21890793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.
    Biederman J; Seidman LJ; Petty CR; Fried R; Doyle AE; Cohen DR; Kenealy DC; Faraone SV
    J Clin Psychiatry; 2008 Jul; 69(7):1150-6. PubMed ID: 18517288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal Trends in the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Stimulant Use in Preschool Children on Medicaid.
    Davis DW; Feygin Y; Creel L; Williams PG; Lohr WD; Jones VF; Le J; Pasquenza N; Ghosal S; Jawad K; Yan X; Liu G; McKinley S
    J Pediatr; 2019 Apr; 207():185-191.e1. PubMed ID: 30545564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
    Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2006 Feb; 27(1):1-10. PubMed ID: 16511362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose Adjustment of Stimulants for Children with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review of the Impact of Exceeding Recommended Doses.
    Ross L; Sapre V; Stanislaus C; Poulton AS
    CNS Drugs; 2020 Jun; 34(6):643-649. PubMed ID: 32300972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of stimulant medications for attention deficit hyperactivity disorder in paediatric congenital heart disease.
    Chung LM; Hariharan G; Varma S
    J Paediatr Child Health; 2023 Mar; 59(3):580-588. PubMed ID: 36789801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention deficit disorder, stimulant use, and childhood body mass index trajectory.
    Schwartz BS; Bailey-Davis L; Bandeen-Roche K; Pollak J; Hirsch AG; Nau C; Liu AY; Glass TA
    Pediatrics; 2014 Apr; 133(4):668-76. PubMed ID: 24639278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of stimulants on sleep characteristics in children with attention deficit/hyperactivity disorder.
    O'Brien LM; Ivanenko A; Crabtree VM; Holbrook CR; Bruner JL; Klaus CJ; Gozal D
    Sleep Med; 2003 Jul; 4(4):309-16. PubMed ID: 14592303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.